Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4740289> ?p ?o }
Showing triples 1 to 52 of
52
with 100 triples per page.
- Q4740289 subject Q6391718.
- Q4740289 subject Q6762709.
- Q4740289 subject Q8301163.
- Q4740289 subject Q8760145.
- Q4740289 abstract "Amarin Corporation is a biopharmaceutical company headquartered in Bedminster, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. Amarin develops the drug Vascepa (AMR-101) which is a prescription grade omega-3 fatty acid. In December 2007, the company acquired Ester Neurosciences Limited for 8.1 million USD. Amarin CEO Joe Zakrzewski has said that the company would like to first work on building its infrastructure out to commercialize the drug in the United States.Recently on July 26, 2012, their lead-candidate drug named Vascepa (AMR-101) received FDA-approval. Vascepa will also be a key competitor against GlaxoSmithKline's Lovaza.".
- Q4740289 foundingYear "1993".
- Q4740289 industry Q7108.
- Q4740289 location Q813922.
- Q4740289 numberOfEmployees "50".
- Q4740289 thumbnail Amarin_logo.jpg?width=300.
- Q4740289 type Q891723.
- Q4740289 wikiPageExternalLink www.amarincorp.com.
- Q4740289 wikiPageExternalLink www.vascepa.com.
- Q4740289 wikiPageExternalLink index.html.
- Q4740289 wikiPageExternalLink www.amarincorp.com.
- Q4740289 wikiPageExternalLink www.vascepa.com.
- Q4740289 wikiPageWikiLink Q1408.
- Q4740289 wikiPageWikiLink Q14859861.
- Q4740289 wikiPageWikiLink Q14890615.
- Q4740289 wikiPageWikiLink Q18032676.
- Q4740289 wikiPageWikiLink Q191756.
- Q4740289 wikiPageWikiLink Q212322.
- Q4740289 wikiPageWikiLink Q28749.
- Q4740289 wikiPageWikiLink Q4334524.
- Q4740289 wikiPageWikiLink Q43656.
- Q4740289 wikiPageWikiLink Q5404453.
- Q4740289 wikiPageWikiLink Q6391718.
- Q4740289 wikiPageWikiLink Q6762709.
- Q4740289 wikiPageWikiLink Q679692.
- Q4740289 wikiPageWikiLink Q7108.
- Q4740289 wikiPageWikiLink Q813922.
- Q4740289 wikiPageWikiLink Q8301163.
- Q4740289 wikiPageWikiLink Q8760145.
- Q4740289 wikiPageWikiLink Q891723.
- Q4740289 foundation "1993".
- Q4740289 industry Q7108.
- Q4740289 location "Bedminster, New Jersey U.S.".
- Q4740289 numEmployees "50".
- Q4740289 type Q891723.
- Q4740289 type Organization.
- Q4740289 type Agent.
- Q4740289 type Company.
- Q4740289 type Organisation.
- Q4740289 type Agent.
- Q4740289 type SocialPerson.
- Q4740289 type Thing.
- Q4740289 type Q43229.
- Q4740289 comment "Amarin Corporation is a biopharmaceutical company headquartered in Bedminster, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. Amarin develops the drug Vascepa (AMR-101) which is a prescription grade omega-3 fatty acid. In December 2007, the company acquired Ester Neurosciences Limited for 8.1 million USD.".
- Q4740289 label "Amarin Corporation".
- Q4740289 depiction Amarin_logo.jpg.
- Q4740289 homepage www.amarincorp.com.
- Q4740289 homepage www.vascepa.com.